Export

Hydralazine
Essential medicine status
General description

INN
Hydralazine
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Essential hypertension
Removed in 2003 (TRS 920) for Essential hypertension
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antihypertensive medicines
  • Parenteral > General injections > IV: 20 mg in ampoule powder for injection (hydrochloride)
  • Oral > Solid: 50 mg tablet; 25 mg tablet (hydrochloride)
  • Oral > Solid: 50 mg (hydrochloride); 25 mg (hydrochloride)